Suppr超能文献

[关于肌痛性脑脊髓炎/慢性疲劳综合征诊断与治疗的跨学科、协作性德奥瑞(德国、奥地利和瑞士)共识声明]

[Interdisciplinary, collaborative D-A-CH (Germany, Austria and Switzerland) consensus statement concerning the diagnostic and treatment of myalgic encephalomyelitis/chronic fatigue syndrome].

作者信息

Hoffmann Kathryn, Hainzl Astrid, Stingl Michael, Kurz Katharina, Biesenbach Beate, Bammer Christoph, Behrends Uta, Broxtermann Wolfgang, Buchmayer Florian, Cavini Anna Maria, Fretz Gregory Sacha, Gole Markus, Grande Bettina, Grande Tilman, Habermann-Horstmeier Lotte, Hackl Verena, Hamacher Jürg, Hermisson Joachim, King Martina, Kohl Sonja, Leiss Sandra, Litzlbauer Daniela, Renz-Polster Herbert, Ries Wolfgang, Sagelsdorff Jonas, Scheibenbogen Carmen, Schieffer Bernhard, Schön Lena, Schreiner Claudia, Thonhofer Kevin, Strasser Maja, Weber Thomas, Untersmayr Eva

机构信息

Allgemeinmedizin, Public Health und Versorgungsforschung, Abteilung für Primary Care Medicine, Zentrum für Public Health, Medizinische Universität Wien, Kinderspitalgasse 15, 1090, Wien, Österreich.

Österreichische Gesellschaft für ME/CFS, Wien, Österreich.

出版信息

Wien Klin Wochenschr. 2024 Aug;136(Suppl 5):103-123. doi: 10.1007/s00508-024-02372-y. Epub 2024 May 14.

Abstract

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a severe, chronic multisystemic disease which, depending on its severity, can lead to considerable physical and cognitive impairment, loss of ability to work and the need for nursing care including artificial nutrition and, in very severe cases, even death.The aim of this D-A-CH (Germany, Austria, Switzerland) consensus statement is 1) to summarize the current state of knowledge on ME/CFS, 2) to highlight the Canadian Consensus Criteria (CCC) as clinical criteria for diagnostics with a focus on the leading symptom post-exertional malaise (PEM) and 3) to provide an overview of current options and possible future developments, particularly with regard to diagnostics and therapy. The D-A-CH consensus statement is intended to support physicians, therapists and valuer in diagnosing patients with suspected ME/CFS by means of adequate anamnesis and clinical-physical examinations as well as the recommended clinical CCC, using the questionnaires and other examination methods presented. The overview of the two pillars of therapy for ME/CFS, pacing and symptom-relieving therapy options, is intended not only to provide orientation for physicians and therapists, but also to support decision-makers from healthcare policy and insurance companies in determining which therapy options should already be reimbursable by them at this point in time for the indication ME/CFS.

摘要

肌痛性脑脊髓炎/慢性疲劳综合征(ME/CFS)是一种严重的慢性多系统疾病,根据其严重程度,可导致相当程度的身体和认知功能损害、工作能力丧失以及需要包括人工营养在内的护理,在非常严重的情况下甚至会导致死亡。本德奥瑞(德国、奥地利、瑞士)共识声明的目的是:1)总结ME/CFS的当前知识状态;2)强调加拿大共识标准(CCC)作为诊断的临床标准,重点关注主要症状——运动后不适(PEM);3)概述当前的选择和未来可能的发展,特别是在诊断和治疗方面。德奥瑞共识声明旨在通过充分的病史采集和临床体格检查以及推荐的临床CCC,利用所提供的问卷和其他检查方法,支持医生、治疗师和评估人员诊断疑似ME/CFS的患者。对ME/CFS的两大治疗支柱——节奏控制和缓解症状的治疗选择的概述,不仅旨在为医生和治疗师提供指导,还旨在支持医疗保健政策制定者和保险公司的决策者确定在此时对于ME/CFS适应症,哪些治疗选择应由他们报销。

相似文献

2
Medical Care Situation of People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in Germany.
Medicina (Kaunas). 2021 Jun 23;57(7):646. doi: 10.3390/medicina57070646.
3
Evaluating case diagnostic criteria for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): toward an empirical case definition.
Disabil Rehabil. 2023 Mar;45(5):840-847. doi: 10.1080/09638288.2022.2043462. Epub 2022 Mar 2.
4
Long-term symptom severity and clinical biomarkers in post-COVID-19/chronic fatigue syndrome: results from a prospective observational cohort.
EClinicalMedicine. 2023 Aug 19;63:102146. doi: 10.1016/j.eclinm.2023.102146. eCollection 2023 Sep.
5
Problems in defining post-exertional malaise.
J Prev Interv Community. 2015;43(1):20-31. doi: 10.1080/10852352.2014.973239.
9
The Role of Psychotherapy in the Care of Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Medicina (Kaunas). 2023 Apr 6;59(4):719. doi: 10.3390/medicina59040719.

本文引用的文献

2
Using cardiorespiratory fitness assessment to identify pathophysiology in long COVID - Best practice approaches.
Prog Cardiovasc Dis. 2024 Mar-Apr;83:55-61. doi: 10.1016/j.pcad.2024.02.005. Epub 2024 Feb 27.
3
Long Covid and Impaired Cognition - More Evidence and More Work to Do.
N Engl J Med. 2024 Feb 29;390(9):858-860. doi: 10.1056/NEJMe2400189.
4
Long COVID is associated with severe cognitive slowing: a multicentre cross-sectional study.
EClinicalMedicine. 2024 Jan 25;68:102434. doi: 10.1016/j.eclinm.2024.102434. eCollection 2024 Feb.
5
One-year follow-up of young people with ME/CFS following infectious mononucleosis by Epstein-Barr virus.
Front Pediatr. 2024 Jan 18;11:1266738. doi: 10.3389/fped.2023.1266738. eCollection 2023.
8
Persistent complement dysregulation with signs of thromboinflammation in active Long Covid.
Science. 2024 Jan 19;383(6680):eadg7942. doi: 10.1126/science.adg7942.
10
Risks of digestive diseases in long COVID: evidence from a population-based cohort study.
BMC Med. 2024 Jan 10;22(1):14. doi: 10.1186/s12916-023-03236-4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验